arrow
E

Eisuke Inoue

showa medical university
H指数:47
被引数:8,886

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Structure–function analysis and exonuclease deletion yield an improved strand-displacing DNA polymerase from Aeribacillus pallidus for efficient recombinase polymerase amplification

结构-功能分析与外切核酸酶缺失获得一种改良的链置换DNA聚合酶,来自Aeribacillus pallidus,用于高效重组聚合酶扩增。

2026-01-020
PRE
Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study

影响日本类风湿关节炎患者阿巴西特治疗中断的因素及按年龄分层的安全性:ORIGAMI研究5年结果

2026-01-010
OA
Intrauterine high-dose intravenous immunoglobulin therapy during pregnancy for women with a history of pregnancy ending in documented neonatal haemochromatosis (NH001): study protocol

妊娠期间对有新生儿血色病(NH001)病史的孕妇进行宫内高剂量静脉免疫球蛋白治疗:研究方案

2025-09-300
OAAI
Comparing immunopathogenesis of non-human immunodeficiency virus immune reconstitution inflammatory syndrome and immune-related adverse events: A prospective multicenter cohort study

比较非人类免疫缺陷病毒免疫重建炎症综合征和免疫相关不良事件的免疫病理机制:一项前瞻性多中心队列研究

2025-03-290
PRE
Promotive clinical effects of pembrolizumab with necitumumab in patients having advanced non-small cell lung cancer with PD-L1 expression of 50% or higher in a phase II study (K-TAIL-202)
2024-04-050
PRE
Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial*
2023-05-017
PRE
Soluble programmed cell death ligand 1 associated with clinical outcome in gastric cancer patients treated with nivolumab: Blood based biomarker analysis of DELIVER trial (JACCRO-GC08AR)
2022-06-011
OA